The Suppression of Puerperal Lactation with Bromocryptine

Publisher Website
Google Scholar
Abstract
The therapeutic value of 2-Br-.alpha.-ergocryptine for the suppression of puerperal lactation was studied in 30 normal women; 16 received the drug, 14 were controls. In 6 women plasma levels of FSH [follicle-stimulating hormone] estradiol and .alpha.-lactalbumin were measured in labor and in the early puerperium. Brom-erocryptine effectively suppressed milk production and alleviated breast pain and congestion, with no side effects and minimum rebound lactation. The inverse relationship between prolactin and FSH levels reported elsewhere in non-pregnant women did not appear to occur in the early postpartum period. Although there was a significant rise in .alpha.-lactalbumin levels in labor and the puerperium over non-pregnant levels, there was no difference between lactating and non-lactating women.

This publication has 0 references indexed in Scilit: